Radiotherapy News and Research

RSS

Radiation therapy (in North America), or radiotherapy (in the UK and Australia) also called radiation oncology, and sometimes abbreviated to XRT, is the medical use of ionizing radiation as part of cancer treatment to control malignant cells (not to be confused with radiology, the use of radiation in medical imaging and diagnosis).

Hyperthermia therapy delivered through BSD Medical's system improves survival rate for bladder cancer patients

BSD Medical Corporation today announced that published study results demonstrated improvement in overall survival, tumor response rates, and local tumor control from the addition of hyperthermia therapy, delivered using the BSD-2000 Hyperthermia System, to the standard treatment regimen for 45 patients with high-risk bladder cancer.

30 Oct 2009

Cancer patients in northern Portugal to gain access to advanced cancer treatments

Cancer patients in northern Portugal will gain access to advanced cancer treatments with the acquisition of seven new treatments machines from Varian Medical Systems (NYSE: VAR) by the Instituto Portugues Oncologia, IPO Porto.

30 Oct 2009

Eisai reports global Phase III study results of eribulin mesylate

Eisai Inc. today announced preliminary results from a recently completed Phase III study with eribulin mesylate (E7389), discovered and developed by the company, in patients with locally advanced or metastatic breast cancer.

30 Oct 2009

ASTRO to host news briefings on top cancer research papers

The American Society for Radiation Oncology (ASTRO) will host four news briefings with accompanying live webcasts on the top cancer research papers from its 51st Annual Meeting.

30 Oct 2009

TomoTherapy radiation therapy platform to be presented at the ASTRO Annual Meeting

TomoTherapy Incorporated announced today that several clinical presentations at the American Society for Radiation Oncology's 51st ASTRO Annual Meeting -- November 1-5, 2009 in Chicago -- will showcase the use of the TomoTherapy® radiation therapy platform as a vital component in the combined modality approach to treating cancer.

30 Oct 2009

Varian Medical Systems to showcase future technologies for managing cancer at the ASTRO

New technology enhancements from Varian Medical Systems, designed to make radiotherapy and radiosurgery treatments faster, more accurate, and easier to plan and deliver, will be on display at the annual meeting of the American Society for Radiation Oncology (ASTRO) in Chicago next week.

29 Oct 2009

Highlights of new cancer research to be presented at 51st ASTRO Annual Meeting

The following are highlights of new cancer research being presented at the American Society for Radiation Oncology's (ASTRO) 51st Annual Meeting on November 1-5, 2009, in Chicago.

29 Oct 2009

First nationwide Prostate Cancer registry for identifying effective treatment options

RemedyMD (www.RemedyMD.com), the leading provider of Patient registry software, today announced the first nationwide Prostate Cancer registry to help clinicians and researchers identify which interventions are most appropriate for specific patient populations.

28 Oct 2009

Combination of treatments for breast cancer

At the end of a 10-year, coast-to-coast study of women with an unusual form of breast cancer, Richard J. Barth Jr., M.D., and three fellow researchers are making the case for a particular combination of treatments to stop the tumors in their tracks.

27 Oct 2009

Resonant Medical to display the next generation of software for its Clarity System

Resonant Medical, an innovator in 3D soft tissue planning, image-guidance and adaptive radiotherapy products, headquartered in Montreal, Canada, today announced that the Company is exhibiting the next generation of software for its Clarity System at the 51st annual American Society of Radiation Oncology (ASTRO) Annual Meeting taking place November 1-5, 2009 in Chicago.

27 Oct 2009

TomoTherapy adds the TomoHD treatment system to its suite of advanced radiation therapy solutions

TomoTherapy Incorporated today announced that it has extended its suite of advanced radiation therapy solutions with the addition of the TomoHD™ treatment system, an efficient, all-purpose new system designed to make it easier for any radiation oncology department to adopt TomoTherapy® technology for its patient population.

22 Oct 2009

Testicular cancer survivors at risk of effective treatment

Testicular cancer survivors can face an increased risk of long-term illness, not because of the malignancy, but the highly effective treatment they receive, according to a study in the urology journal BJUI.

20 Oct 2009

Antioxidant extracts of G.biloba leaves may protect cells from radiation damage

Antioxidant extracts of the leaves of the Gingko biloba tree may protect cells from radiation damage, according to a study published in the International Journal of Low Radiation. The discovery may one day be used to help reduce side effects in cancer patients undergoing radiotherapy.

20 Oct 2009

Yashoda Cancer Institute in India to expand use of Varian Medical Systems' RapidArc radiotherapy

A hospital that is using RapidArc radiotherapy to treat cancers of the head & neck and cervix is announcing it will be expanding its use for treatment of other cancers. Yashoda Cancer Institute in Hyderabad has found it can deliver image-guided, intensity modulated radiotherapy (IMRT) faster and more precisely using the RapidArc technology from Varian Medical Systems.

19 Oct 2009

Antisense Pharma's SAPPHIRE Phase III trial evaluating trabedersen approved by Health Canada

The biopharmaceutical company Antisense Pharma GmbH has announced today that it has received the approval by Health Canada for its pivotal Phase III clinical trial SAPPHIRE in patients with recurrent or refractory anaplastic astrocytoma.

19 Oct 2009

BJUI: Testicular cancer survivors face an increased risk of long-term illness due to effective treatment

19 Oct 2009

Access Pharmaceuticals' update on its European commercial launch of Mugard

ACCESS PHARMACEUTICALS, INC. today provided an update on its European commercial launch of MuGard, an FDA approved treatment for oral mucositis, a debilitating side effect of radiation treatment and chemotherapy.

15 Oct 2009

Genes to determine which rectal cancer patient can avoid surgical procedure for treatment

A set of 87 genes one day may be used to routinely determine which patients can be successfully treated for advanced rectal cancer without undergoing a surgical procedure, researchers announced at the 2009 Clinical Congress of the American College of Surgeons.

15 Oct 2009

Cytheris initiates Phase I/IIa dose escalation study of patients suffering from ICL

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the initiation of a Phase I/IIa dose escalation study of patients suffering from idiopathic CD4 lymphocytopenia (ICL).

15 Oct 2009

Riga Eastern Clinical University Hospital commences treatment with the Novalis Tx radiosurgery platform

Doctors in Latvia have begun treatments using the region's first Novalis Tx(TM) radiosurgery platform from Varian Medical Systems and BrainLAB. Two prostate cancer patients have been treated using Varian's RapidArc® radiotherapy technology at the Riga Eastern Clinical University Hospital.

14 Oct 2009

Radiotherapy News and Research

Further Reading

Hyperthermia therapy delivered through BSD Medical's system improves survival rate for bladder cancer patients

Cancer patients in northern Portugal to gain access to advanced cancer treatments

Eisai reports global Phase III study results of eribulin mesylate

ASTRO to host news briefings on top cancer research papers

TomoTherapy radiation therapy platform to be presented at the ASTRO Annual Meeting

Varian Medical Systems to showcase future technologies for managing cancer at the ASTRO

Highlights of new cancer research to be presented at 51st ASTRO Annual Meeting

First nationwide Prostate Cancer registry for identifying effective treatment options

Combination of treatments for breast cancer

Resonant Medical to display the next generation of software for its Clarity System

TomoTherapy adds the TomoHD treatment system to its suite of advanced radiation therapy solutions

Testicular cancer survivors at risk of effective treatment

Antioxidant extracts of G.biloba leaves may protect cells from radiation damage

Yashoda Cancer Institute in India to expand use of Varian Medical Systems' RapidArc radiotherapy

Antisense Pharma's SAPPHIRE Phase III trial evaluating trabedersen approved by Health Canada

BJUI: Testicular cancer survivors face an increased risk of long-term illness due to effective treatment

Access Pharmaceuticals' update on its European commercial launch of Mugard

Genes to determine which rectal cancer patient can avoid surgical procedure for treatment

Cytheris initiates Phase I/IIa dose escalation study of patients suffering from ICL

Riga Eastern Clinical University Hospital commences treatment with the Novalis Tx radiosurgery platform

Cancer Research eBook

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News